PNC Financial Services Group’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
PLC
GCP
OC
MAM
JJ
YIH
PNC Financial Services Group's LAB Position: Q2 2026 in Review
PNC Financial Services Group held its Standard BioTools (LAB) position steady in Q2 2026 at 128 shares worth $105. The position accounts for ﹤0.01% of the portfolio, ranked #5143.
PNC Financial Services Group first reported a position in LAB in Q2 2013 and has held it in 29 quarters since. The position peaked at $14K in Q1 2015. 40 funds tracked by Wall St. Rank hold LAB as of Q2 2026.
- PNC Financial Services Group held 128 shares of Standard BioTools worth $105 as of Q2 2026.
- PNC Financial Services Group left its Standard BioTools share count unchanged in Q2 2026.
- Standard BioTools made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5143 holding.
- PNC Financial Services Group first reported a position in Standard BioTools in Q2 2013 and has held it in 29 quarters since.
- PNC Financial Services Group's Standard BioTools position peaked at $14K in Q1 2015.
- 40 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.